Paris Biotech Santé

Sep 25, 2017

Exeliom Biosciences joins Paris Biotech Santé Incubator

#funding #SeriesA #Clinicaltrials

Jun 30, 2023

Exeliom Biosciences Announces Series A Extension and Final Closing with Total of €24 Million ($26 Million) to Progress the Clinical Development of its Lead Candidate in Immuno-Oncology and Infectious Diseases.

Mar 4, 2024

Exeliom is awarded a $500k grant from the Crohn's and Colitis Foundation!

Nextbiotix Exeliom Biosciences

Feb 15, 2019

Nextbiotix becomes Exeliom Biosciences

contact

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.